{
    "clinical_study": {
        "@rank": "115820", 
        "arm_group": {
            "arm_group_label": "dexmedetomidine continuous infusion", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "Patients undergoing shoulder arthroscopy in the beach chair position may be at risk for\n      adverse neurologic events due to cerebral ischemia.\n\n      Dexmedetomidine, a potent alpha adrenoceptor agonist which dose-dependently reduces arterial\n      blood pressure and heart rate, decreases the hemodynamic and catecholamine response in the\n      perioperative period.\n\n      dexmedetomidine has an effect of peripheral vasoconstriction thus it is theologically\n      appropriate for reducing bleeding for arthroscopic operation field.\n\n      The aim of this study is to evaluate the efficacy and the safety of dexmedetomidine on\n      cerebral oxygen saturation, cognitive function, hemodynamic stability and operative field in\n      patients undergoing arthroscopic shoulder surgery in the beach-chair position."
        }, 
        "brief_title": "Evaluation of Efficacy and Safety of General Anesthesia Using Dexmedetomidine With Sevoflurane in Patients Undergoing Arthroscopic Shoulder Surgery: Preliminary Study", 
        "completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "condition": "Arthroscopic Shoulder Surgery in the Beach-chair Position", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  ASA I-II\n\n          -  Aged between 20 and 70 year\n\n          -  general anesthesia for arthroscopic shoulder surgery in the beach-chair position\n\n        Exclusion Criteria:\n\n          -  Congestive heart failure, coronary artery occlusive disease\n\n          -  Bradycardia < 50 BPM, 2nd degree < AV block\n\n          -  Poorly controlled hypertension\n\n          -  \u00df blocker medication\n\n          -  Coagulopathy\n\n          -  Pregnancy, nursing"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "19", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 5, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01687868", 
            "org_study_id": "4-2012-0351"
        }, 
        "intervention": {
            "arm_group_label": "dexmedetomidine continuous infusion", 
            "description": "dexmedetomidine 0.7mcg/kg/hr continuous infusion", 
            "intervention_name": "Dexmedetomidine", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Dexmedetomidine"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 4, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "120-752"
                }, 
                "name": "Department of Anesthesiology and Pain Medicine,Yonsei University Health System"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "1", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Before the anesthetic induction(T1), Before endotracheal intubation(T2), After endotracheal intubation(T3), Before the beach-chair position(T4), 5 minutes after the beach-chair position(T5), Before the operation(T6), 5 minutes after the incision(T7), After removal of the arthroscopy(T8), at the end of the operation(T9)", 
            "measure": "Regional cerebral oxygen saturation value", 
            "safety_issue": "No", 
            "time_frame": "T1,T2,T3, T4, T5,T6, T7, T8, T9 time of post-dose during surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01687868"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Yonsei University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Yonsei University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}